MRI-based assessment of residual disease after neoadjuvant chemotherapy in pregnant women with cervical cancer. Russo L, D'Erme L, Bottazzi S, Amerighi A, et al. Eur J Radiol 2024;181:111766.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Russo L, D'Erme L, Bottazzi S, Amerighi A, et al. MRI-based assessment of residual disease after neoadjuvant chemotherapy in pregnant women with cervical cancer. Eur J Radiol 2024;181:111766.
PMID: 39509748